Cytokinetics, Inc. (CYTK)
65.60
-0.02
(-0.03%)
USD |
NASDAQ |
Oct 02, 16:00
65.59
-0.01
(-0.02%)
After-Hours: 20:00
Cytokinetics Gross Profit Margin (Quarterly) : 67.78% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.78% |
| March 31, 2026 | 69.36% |
| December 31, 2025 | 83.89% |
| September 30, 2025 | -38.38% |
| June 30, 2025 | 96.58% |
| March 31, 2025 | -45.66% |
| December 31, 2024 | 85.92% |
| September 30, 2024 | -420.7% |
| June 30, 2024 | -866.3% |
| March 31, 2024 | -179.2% |
| December 31, 2023 | -278.9% |
| September 30, 2023 | -390.5% |
| June 30, 2023 | -221.9% |
| March 31, 2023 | 39.67% |
| December 31, 2022 | -40.06% |
| September 30, 2022 | 16.98% |
| June 30, 2022 | 97.75% |
| March 31, 2022 | -36.59% |
| December 31, 2021 | 95.17% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 98.45% |
| September 30, 2015 | 98.16% |
| June 30, 2015 | 97.75% |
| March 31, 2015 | 96.72% |
| December 31, 2014 | 99.37% |
| September 30, 2014 | 98.66% |
| June 30, 2014 | 98.43% |
| March 31, 2014 | 98.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 67.95% |
| Ionis Pharmaceuticals, Inc. | 96.13% |
| Vertex Pharmaceuticals, Inc. | 85.37% |
| Krystal Biotech, Inc. | 93.46% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -61.36% |
| Return on Invested Capital | -133.5% |
| Profit Margin (Quarterly) | -694.4% |
| Operating Margin (Quarterly) | -626.0% |
| Return on Net Operating Assets | -542.7% |